Opioids

The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to severe acute pain in adults.
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage, director of population health at Englewood Hospital, discuss what Englewood Health is doing to prevent opioid use in its communities and how an…
Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to meet the behavioral health needs of its communities.
The American Hospital Association (AHA) today announced it has been awarded nearly $1.5 million in funding from the Centers for Disease Control and Prevention (CDC) as part of its National Partners Cooperative Agreement. This funding will support hospitals and health systems in their efforts to…
General Information Page

May is Mental Health Awareness Month

Join us in celebrating Mental Health Awareness Month 2024 and learn how hospitals and health systems are addressing behavioral health care.
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and other solid forms of prescription drugs.
The majority of overdose deaths in the United States involve opioids.
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from entering the U.S. from India, the Food and Drug Administration reported Friday.
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act of 2018, AHA June 14 encouraged its Subcommittee on Health to consider certain…
While counseling and other services are an important part of a comprehensive treatment plan for opioid use disorder, the provision of medication should not be made contingent upon participation in such services, the Food and Drug Administration and Substance Abuse and Mental Health Services…